Vivodyne, Inc. is an exciting startup from Penn Bioengineering that’s creating a platform technology to answer a pressing question in biotech: how can we improve the accuracy, speed, and breadth of the modern drug development pipeline?

They are creating a groundbreaking 3D tissue culture pipeline and statistical inference engine to test drugs, biologics, and immunotherapies directly on ultra-realistic , bioengineered human tissues. All at pharmaceutical-grade throughput.

Startup Details

Founded by:

Counsel: Cooley

Seed Investor: Kairos

Skip to content